Advertisement
Screener

MYRIAD GENETICS, INC. (MYGN) Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One

2.1 / 5 stars · 50/120 Roast Me

MYRIAD GENETICS, INC. Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One

MYRIAD GENETICS, INC. (MYGN) had Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One of $4.90 million as of 2024-06-30, per its 10-Q filed 2024-08-07.

Discontinued › Notes › Investments › Available-for-Sale Securities, Debt Maturities › Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Fair Value

us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue · last filed 2024-08-07

  • 2024-06-30: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One $4.90M.
  • 2024-03-31: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One $7.40M.
  • 2023-12-31: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One $8.80M.
  • 2023-09-30: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One $10.30M.
Period endDebt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One
2024-06-30$4.90M
10-Q · filed 2024-08-07
2024-03-31$7.40M
10-Q · filed 2024-05-08
2023-12-31$8.80M
10-K · filed 2024-02-28
2023-09-30$10.30M
10-Q · filed 2023-11-07
2023-06-30$18.80M
10-Q · filed 2023-08-04
2023-03-31$25.10M
10-Q · filed 2023-05-04
2022-12-31$58.00M
10-K · filed 2023-03-01
2022-09-30$82.50M
10-Q · filed 2022-11-02
2022-06-30$99.90M
10-Q · filed 2022-08-05
2022-03-31$103.20M
10-Q · filed 2022-05-06
2021-12-31$80.40M
10-K · filed 2022-02-25
2021-09-30$70.90M
10-Q · filed 2021-11-04
2021-06-30$46.00M
10-Q · filed 2021-08-04
2021-03-31$27.20M
10-Q · filed 2021-05-05
2020-12-31$33.70M
10-KT · filed 2021-03-16
2020-06-30$54.10M
10-K · filed 2020-08-13
2020-03-31$60.50M
10-Q · filed 2020-05-06
2019-12-31$62.70M
10-Q · filed 2020-02-07
2019-09-30$55.00M
10-Q · filed 2019-11-06
2019-06-30$47.00M
10-K · filed 2019-08-13
2019-03-31$66.20M
10-Q · filed 2019-05-08
2018-12-31$74.80M
10-Q · filed 2019-02-06
2018-09-30$75.60M
10-Q · filed 2018-11-07
2018-06-30$69.70M
10-K · filed 2018-08-24
2018-03-31$59.90M
10-Q · filed 2018-05-09
2017-12-31$54.80M
10-Q · filed 2018-02-07
2017-09-30$60.40M
10-Q · filed 2017-11-08
2017-06-30$48.30M
10-K · filed 2017-08-09
2017-03-31$48.30M
10-Q · filed 2017-05-03
2016-12-31$54.40M
10-Q · filed 2017-02-08
2016-09-30$61.50M
10-Q · filed 2016-11-02
2016-06-30$90.50M
10-K · filed 2016-08-10
2016-03-31$96.20M
10-Q · filed 2016-05-04
2015-12-31$84.60M
10-Q · filed 2016-02-03
2015-09-30$68.00M
10-Q · filed 2015-11-04
2015-06-30$80.70M
10-K · filed 2015-08-12
2015-03-31$79.22M
10-Q · filed 2015-05-06
2014-12-31$105.41M
10-Q · filed 2015-02-04
2014-09-30$89.81M
10-Q · filed 2014-11-05
2014-06-30$121.64M
10-K · filed 2014-08-13
2014-03-31$126.36M
10-Q · filed 2014-05-07
2013-12-31$282.00M
10-Q · filed 2014-02-05
2013-09-30$272.03M
10-Q · filed 2013-11-12
2013-06-30$268.24M
10-K · filed 2013-08-14
2013-03-31$223.83M
10-Q · filed 2013-05-08
2012-12-31$290.21M
10-Q · filed 2013-02-06
2012-09-30$253.58M
10-Q · filed 2012-11-09
2012-06-30$254.18M
10-K · filed 2012-08-15
2012-03-31$232.51M
10-Q · filed 2012-05-02
2011-12-31$241.78M
10-Q · filed 2012-02-01
2011-09-30$286.85M
10-Q · filed 2011-11-02
2011-06-30$293.78M
10-K · filed 2011-08-15

Similar stocks

Stock NameCountryMarket CapPE Ratio
Alpha Teknova, Inc. (TKNO)United States$0.500B-18.12
Insight Molecular Diagnostics Inc. (IMDX)United States$0.129B-3.90
IMMUCELL CORP /DE/ (ICCC)United States$0.091B116.10
QuidelOrtho Corp (QDEL)United States$0.733B-0.90
BIOMERICA INC (BMRA)United States$0.011B
Q/C TECHNOLOGIES, INC. (QCLS)United States$0.008B-1.93
Cardio Diagnostics Holdings, Inc. (CDIO)United States$0.006B
VOLITIONRX LTD (VNRX)$0.003B-0.64
ACHIEVE LIFE SCIENCES, INC. (ACHV)United States$0.806B-5.88
Intellia Therapeutics, Inc. (NTLA)United States$1.705B-5.92